Diagnostic implications of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index for gastric carcinoma

Table 3 Analysis of risk factors affecting gastric carcinoma

Variable	β	SE	Wald	P value	Exp (β)	95%CI
Gender	0.974	0.365	7.111	0.008	2.649	1.295-5.420
Age (year)	0.033	0.017	3.755	0.053	1.034	1.000-1.069
BMI (kg/m2)	-0.145	0.063	5.325	0.021	0.865	0.765-0.978
Neutrophil count	-0.457	0.704	0.421	0.517	0.633	0.159-2.519
Lymphocyte count	0.718	0.400	3.213	0.073	2.049	0.935-4.491
Platelet count	-0.004	0.012	0.106	0.745	0.996	0.972-1.020
NLR	0.293	1.428	0.042	0.837	1.340	0.082-22.007
PLR	-0.002	0.016	0.012	0.911	0.998	0.968-1.030
SII	0.012	0.008	2.118	0.146	1.012	0.996-1.029

95%CI: 95% confidence interval; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; SII: Systemic immune-inflammatory index; BMI: Body mass index.